
Northwestern Medicine scientists have developed a promising approach to killing treatment-resistant cancer cells by exploiting their hidden metabolic vulnerabilities, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).

Northwestern Medicine scientists have uncovered new details about how poxvirus hijacks its host’s protein synthesis machinery to multiply and spread, according to a study published in Nature Microbiology.

Genetic makeup and structure can shift dramatically across different areas of a single glioblastoma tumor, reveals a Northwestern Medicine study published in Science Advances.

A newly developed scoring system could enhance risk prediction and guide treatment decisions for colorectal cancer, according to a study published in the Journal of Clinical Oncology.

Northwestern Medicine investigators have discovered that a novel long noncoding RNA, which are usually 200 nucleotides longer than typical RNAs, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances.

A pair of recent studies from the laboratory of Bin Zhang, MD, PhD, the Johanna Dobe Professor of Cancer Immunology, have uncovered new details about critical immunological processes that may help improve cancer treatments, according to the findings.

Patients and families joined faculty, students and trainees on May 15 for Alzheimer Day, an annual event hosted by the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease to showcase dementia and aging research conducted throughout Northwestern and bring those discoveries to the community.

Feinberg honored the MD Class of 2025 during the medical school’s 166th commencement ceremony held in the Aon Grand Ballroom at Navy Pier on May 19.

Specific cannabinoids produced by the human body may help to quell excessive fear responses in people with post-traumatic stress disorder and anxiety, according to a Northwestern Medicine-led study published in the Journal of Clinical Investigation.

Biomarkers used to predict heart failure risk in the general population may be ineffective for assessing risk after pregnancies complicated by hypertension or diabetes, according to a study published in JAMA Cardiology.